
30%
of the US population use low-dose aspirin for Cardiovascular disease prevention.2


of the US population use low-dose aspirin for Cardiovascular disease prevention.2

of surgical patients are treated with anticoagulants and/or antiplatelets.*3,4
*Based on Premier Database data

adults will be diagnosed with cancer in their lifetime.5

The risk of bleeding in cardiac surgery is especially high due to the invasiveness of procedures, need for anticoagulation, and exposure to cardiopulmonary bypass.6
of annual U.S. blood transfusions are accounted for in cardiovascular procedures.7
of all cardiovascular surgery patients will receive blood transfusions.8,9
of U.S. cardiovascular surgery patients will require reoperation for bleeding.10
Increased hospital length of stay and increased costs are associated with bleeding-related complications and/or transfusions. This supports the implementation of blood conservation strategies. 11

Failure to achieve and maintain hemostasis may lead to excessive bleeding, thereby complicating surgery and increasing the risk of morbidity and mortality.

Understanding your patient’s coagulation factors preoperatively and intraoperatively assessing the grade of bleed you encounter can influence your choice in hemostat.12 A hemostatic strategy can be instrumental in minimizing blood loss in cardiovascular surgery.8,9

Achieving a strong and durable seal may reduce blood transfusions and drainage in cardiovascular surgery.14,15

At Baxter, we are dedicated to maintaining strong connections with societies that are pivotal to ensuring your success in the operating room.

Stay up to date with the latest cardiac events and resources